Does surgery and radiotherapy really improve the prognosis of patients with small-cell esophageal carcinoma?
Kexun Li(Nankai University), Yunchao Huang(North China University of Water Resources and Electric Power), Jie Mao(Jinan University)
Cited by 0
Related Papers
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
|Lung Cancer|2018|134
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
|Molecular Cancer|2023|120